BioNexus Gene Lab (BGLC) P/B (2020 - 2026)
BioNexus Gene Lab (BGLC) P/B from Sep 16, 2020 to Jul 21, 2026. The TTM BioNexus Gene Lab (BGLC) P/B is 0.48. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of BioNexus Gene Lab (BGLC)
| Year | P/B | Change |
|---|---|---|
| 2026 | 0.48 | -56.89% |
| 2025 | 1.11 | +83.60% |
| 2024 | 0.60 | -37.93% |
| 2023 | 0.97 | -96.21% |
| 2022 | 25.70 | -49.39% |
| 2021 | 50.77 | -14.10% |
| 2020 | 59.11 | N/A |
Comparison BioNexus Gene Lab (BGLC) P/B with competitors
BioNexus Gene Lab (BGLC) P/B is 0.48.